Page 52 - AN-1-1
P. 52

Advanced Neurology                                                          EPAC2 null leads to tauopathy




            Table 1. Primary antibodies used for Western blot analysis   homogenized in radio immunoprecipitation assay (RIPA)
            and immunohistochemistry                           buffer containing 50 mM Tris-HCl, 150 mM NaCl, 20 mM
                                                               EDTA, 1% Nonidet-P40, 1 mM phenylmethylsulfonyl
             Antibody  Specificity  Type  Dilution  Dilution  Source
                                     (WB)    (IHC)             fluoride  (PMSF),  50  mM  NaF,  and  0.25%  sodium
            pT205   P-tau at Thr205 pAb  1:1000  1:200  Biosource  deoxycholate, and centrifuged at 12,000 ×g for 30 min at
                                                               4°C. The supernatant was collected, and after evaporation
            pT231   P-tau at Ser231 pAb  1:1000    Biosource   of  the  formic  acid  in a  speed vacuum,  the pellet  was
            pS396   P-tau at Ser396 pAb  1:1500  1:200  Biosource  resuspended in sodium dodecyl sulfate-polyacrylamide
            pS404   P-tau at Ser404 pAb  1:1500    Biosource   gel  electrophoresis  (SDS-PAGE)  sample  buffer
            P35/25  Total P25/25  pAb  1:1000      Cell        (240 mM Tris-HCl, pH  6.8, 6% SDS, 30% glycerol, and
                                                   signaling   0.06% bromophenol blue). The RIPA fraction and the
            CDK5    Total CDK5  mAb  1:1000        Abcam       formic acid fraction contained relatively soluble tau and
            P35     P35        pAb    1:500        Santa Crus  detergent-insoluble tau, respectively, and were sonicated
            p35/p25  P35 and P25  mAb  1:500       Cell        extensively before immunoblotting.
                                                   signaling   2.7. Western blotting
            TAU-1   Non-       mAb    1:500        Millipore
                    phosphorylated                             The animals were decapitated under chloral hydrate
                    tau                                        (600  mg/kg, i.p.) anesthesia, and the hippocampi were
            TAU-46  Total tau  mAb   1:1000        Millipore   rapidly removed and homogenized at 4°C using a Teflon
            EPAC2   Epac2      pAb    1:500        Santa Crus  glass homogenizer in a reagent containing 50 mM Tris-
            DM1A    α-tubulin  mAb   1:1000        Sigma       HCl (pH  7.4), 1 mM Na VO , 150 mM NaCl, 10 mM
                                                                                    3
                                                                                        4
                                                               NaF, 5 mM EDTA, 2 mM benzamidine, 1 mM PMSF,
            WB: Western blot; IHC: Immunohistochemistry; pAb: Polyclonal   and proteinase inhibitor cocktail (1:100 dilution). Three
            antibody; mAb: Monoclonal antibody.
                                                               volumes  of  the  homogenized tissue  were  added to  one
            reverse transcribed to cDNA with the use of FastKing One   volume of extraction buffer containing 200 mM Tris-HCl,
            Step RT-PCR kit (Tiangen, Beijing, China).         pH 7.6, 8% SDS, 40% glycerol, and 40 mM dithiothreitol,
                                                               and then, the mixture was placed in a boiling water
              The primer sequences for EPAC2 were as follows: (Forward   bath for 10 min. Next, the lysates were sonicated briefly
            primer)  5ʹ-AACTGGTATGCTGTCCTGGC-3ʹ        and     and centrifuged at 12,000 ×g for 5 min. The supernatant
            (reverse primer) 5ʹ-TAGGGAGGAGCCAGAAGTCC-3ʹ.       was stored at −80°C for Western blotting. The protein
            The primer sequences for β-actin were as follows: (Forward   concentration  of  supernatants  was  measured  using
            primer) 5ʹ-AGCCTTCCTTCTTGGGTAT-3ʹ and (reverse     the Pierce BCA Protein Assay Kit, according to the
            primer)  5ʹ-GCTCAGTAACAGTCCGCCTA-3ʹ.       The     manufacturer’s instructions. The proteins were separated
            primers used in this experiment were produced by Tsingke   by 10% SDS-PAGE and transferred to a nitrocellulose
            Biotechnology (Beijing, China).                    membrane. After blocking in 3% bovine serum albumin
                                                               for 1 h at 25°C, the membranes were incubated first with
              RT-PCR was performed on a PCR thermocycler (Bio-  primary antibodies at 4°C overnight and then with anti-
            Rad, New York, USA). Reactions were prepared in a total   mouse or anti-rabbit IgG conjugated to IRDye 800CW as
            volume of 50 μL containing 0.5 μg cDNA, 2 μL of each 10   secondary antibody for 1 h at 25°C. Protein expression was
            μM primer, and 25 μL of Taq MasterMix (Cwbio, Beijing,   then visualized with the Odyssey Infrared Imaging System
            China).                                            (LI-COR Biosciences).

            2.5. Calpain activity assay                        2.8. Immunohistochemistry and Bielschowsky silver
            Analysis of calpain activity in the hippocampus was   staining
            performed using a calpain activity fluorometric assay   The mice were anesthetized with chloral hydrate
            kit  (catalog  no. GMS50046.2,  Genmed Scientifics  Inc.,   (600 mg/kg, i.p.) and immediately perfused with 200 mL
            Shanghai, China). All the experimental procedures were   normal saline followed by 200 ml phosphate buffer (4°C)
            carried out, according to the manufacturer’s instructions.  containing 4% paraformaldehyde. The brains were then
                                                               post-fixed in perfusate at 4°C for 24 h. Paraffin-embedded
            2.6. Preparation of the sarkosyl-insoluble fraction
                                                               brain sections were prepared for immunostaining after
            The detection of soluble and insoluble tau was performed   xylene treatment and progressive rehydration with 70–100%
            as described previously . In brief, the hippocampi were   ethanol. Sections were blocked and then incubated with
                               [20]


            Volume 1 Issue 1 (2022)                         3                         https://doi.org/10.36922/an.v1i1.8
   47   48   49   50   51   52   53   54   55   56   57